This event has ended. Visit the official site or create your own event on Sched.
Back To Schedule
Wednesday, June 29 • 4:00pm - 5:00pm
#367: Quality at the Edge(s): Design It Right and Keep It Going in Non-Interventional Studies

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Limited Capacity seats available

Component Type: Session
Level: Intermediate
CE: CME 1.00; IACET 1.00; RN 1.00

Quality must be assured at all stages of clinical development. Quality planning and risk management begins well before the first protocol for a clinical program is drafted and continues through the life cycle of the product, including postmarking studies. Approaches, including protocols assessment by cross-functional teams and development of control strategies, can identify and address risks before the study starts. At the other end of the clinical development cycle, interest in postmarketing, noninterventional studies is increasing from both the regulatory perspective and their potential support new indications. This session will discuss how these studies have their own set of challenges, yet proper oversight can be achieved through innovative approaches.

Learning Objectives

Describe a framework to reduce risk in early-phase trials; Identify how to drive value from the protocol review stage; Discuss the necessity and challenges of cross-functional risk assessment; Describe the current landscape and expectations for sponsors of non-interventional research; Recognize oversight activities with respect to challenges of postmarketing observational trials; Discuss innovative solutions for overcoming the challenges through risk adapted surveillance activities.


David William Fryrear, MSc


A Proactive QRM Framework that Breaks Down Functional Silos and Drives Higher Quality into Clinical Trials
Tim Strauss, MS

Sponsor Oversight of Non-Interventional Research
Christine R. Sahagian, MS

avatar for David Fryrear

David Fryrear

Senior Director, R&D Quality Assurance, AbbVie, Inc.
David Fryrear is a Senior Director in R&D Quality Assurance at AbbVie.  In this role, he is the global head of clinical and pharmacovigilance quality assurance and has responsibility for R&D documentation standards and Quality Knowledge Management.  Prior to joining AbbVie in January... Read More →


Christine Sahagian

Head, Clinical and Medical QA and Compliance, Shire US Inc
Christine is Head of Clinical and Medical QA and Compliance at Shire. She began her career with clinical trial operations responsibilities at Parexel and CareStat/Battelle CRO. Christine has also had roles in Outsourcing and Clinical QA and Compliance at Vertex, Biogen, and Cubist... Read More →
avatar for Tim Strauss

Tim Strauss

President, Quality Solutions, QI Path

Wednesday June 29, 2016 4:00pm - 5:00pm EDT
204A Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA